ViaLase®
News
Check back here for the latest updates on our research and clinical studies, as well as industry coverage about the ViaLuxe™ Laser System.
1 2 Next »April 1, 2024 | Press Release
ViaLase Closes $40 million Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma
Read MoreOctober 30, 2023 | Press Release
ViaLase Completes Enrollment for the Pivotal VIA-002 Trial of the ViaLase® Laser to Treat Primary Open Angle Glaucoma
Read MoreMay 30, 2023 | Press Release
ViaLase to Present Clinical Data at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Read MoreApril 18, 2023 | Press Release
ViaLase to Present New Scientific Data at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Read MoreApril 18, 2023 | Press Release
Vialase Announces Publication of 24-Month Safety Data from First-in-Human Study of Femtosecond Laser Image-Guided High-Precision Trabeculotomy (FLigHT)
Read MoreSign up for our newsletter below and be sure to follow us on social media.
